TipRanks
TipRanksTop Financial ExpertsInsidersTerrie Curran

Terrie Curran Insider Profile

4 Followers
Terrie Curran, Director at Arcutis Biotherapeutics, holds 23.53K shares in Arcutis Biotherapeutics (Ticker: ARQT), holds 364.31K shares in Phathom Pharmaceuticals (Ticker: PHAT), holds 0.00 shares in Myovant Sciences (Ticker: MYOV). Most recently, Terrie Curran Sold ― shares of Arcutis Biotherapeutics on Aug 28, 2026 for an estimated value of $955.76K.
See the Hottest Stocks Based on Insider Trading >
tipranks
Terrie Curran

Terrie Curran
Arcutis Biotherapeutics (ARQT)
Director

Ranked #49,429 out of 109,287 Corporate Insiders

Profitable Transactions

63%
5 out of 8 Profitable Transactions

Average Return

+0.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$3M
74.54%
25.46%
A breakdown of Terrie Curran's holdings
See the Top Stocks by Insiders

Insider Roles

Phathom Pharmaceuticals
(PHAT)
President & CEO, Director
Arcutis Biotherapeutics
(ARQT)
Director
Roles that Terrie Curran holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Phathom Pharmaceuticals
(PHAT)
Rating:Informative Sell
Date:Mar 23, 2021 - Mar 23, 2022
Return:+66.80%
The most profitable trade made by Terrie Curran
See the Latest Stocks Traded by Insiders

Terrie Curran's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ARQT
Arcutis Biotherapeutics
Aug 28, 2026
Director
Informative Sell
955.76K
$745.30K
CELG
Celgene
Nov 22, 2019
―
Uninformative Sell
―
$567.07K
MYOV
Myovant Sciences
Mar 10, 2023
―
Uninformative Sell
―
$0.00
PHAT
Phathom Pharmaceuticals
Jan 23, 2025
President & CEO, Director
Uninformative Sell
125.74K
$2.18M
List of latest transactions for each holding click on a transaction to see Terrie Curran's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Terrie Curran insider profile FAQ

What is the percentage of profitable transactions made by Terrie Curran?
The percentage of profitable transactions made by Terrie Curran is 63%.
    What is the average return per transaction made by Terrie Curran?
    The average return per transaction made by Terrie Curran is 0.60%.
      What stocks does Terrie Curran hold?
      Terrie Curran holds: ARQT, CELG, MYOV, PHAT stocks.
        What was Terrie Curran’s latest transaction?
        Terrie Curran latest transaction was an Informative Sell of $955.76K.
          What was Terrie Curran's most profitable transaction?
          Terrie Curran’s most profitable transaction was an Informative Sell of PHAT stock on March 23, 2021. The return on the trade was 66.80%.
            What is Terrie Curran's role in Arcutis Biotherapeutics?
            Terrie Curran's role in Arcutis Biotherapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.